Fair value of Financial Instruments (Tables)
|
6 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Summary of Unobservable Inputs and Ranges |
Our Level 3 valuation techniques, unobservable inputs and ranges were categorized as follows for ASC 820 purposes ($ in thousands):
|
|
|
|
|
|
|
|
|
|
|
Asset Category |
|
Fair value at March 31, 2026 |
|
|
Valuation Technique |
|
Unobservable Input |
|
Range of Input (Weighted Average) (1) |
First lien |
|
$ |
92,244 |
|
|
Market Comparable |
|
Broker/Dealer bids or quotes |
|
N/A |
First lien |
|
|
2,092,114 |
|
|
Market Comparable |
|
Market yield |
|
7.0% - 20.1% (9.6%) |
First lien |
|
|
62,964 |
|
|
Enterprise Market Value |
|
EBITDA multiple |
|
6.5x - 17.9x (13.2x) |
First lien |
|
|
4,806 |
|
|
Market Comparable |
|
Revenue multiple |
|
0.9x |
Subordinated debt |
|
|
14,528 |
|
|
Market Comparable |
|
Market yield |
|
12.0% - 25.0% (15.5%) |
Subordinated debt |
|
|
4,285 |
|
|
Enterprise Market Value |
|
EBITDA multiple |
|
7.5% - 26.2% (24.3%) |
Equity |
|
|
221,345 |
|
|
Enterprise Market Value |
|
EBITDA multiple |
|
1.3x - 28.0x (14.4x) |
Total Level 3 investments |
|
$ |
2,492,286 |
|
|
|
|
|
|
|
Long-Term Credit Facility |
|
$ |
328,333 |
|
|
Market Comparable |
|
Market yield |
|
5.5% |
____________________________________________ (1)The weighted averages disclosed in the table above were weighted by their relative fair value.
|
|
|
|
|
|
|
|
|
|
|
Asset Category |
|
Fair value at September 30, 2025 |
|
|
Valuation Technique |
|
Unobservable Input |
|
Range of Input (Weighted Average) (1) |
First lien |
|
$ |
114,625 |
|
|
Market Comparable |
|
Broker/Dealer bids or quotes |
|
N/A |
First lien |
|
|
2,377,201 |
|
|
Market Comparable |
|
Market Yield |
|
4.0% - 24.5% (9.9%) |
First lien |
|
|
17,969 |
|
|
Enterprise Market Value |
|
EBITDA multiple |
|
8.3x |
First lien |
|
|
3,836 |
|
|
Market Comparable |
|
Revenue Multiple |
|
0.6x |
Second Lien |
|
|
995 |
|
|
Market Comparable |
|
Broker/Dealer bids or quotes |
|
N/A |
Subordinated debt |
|
|
17,439 |
|
|
Market Comparable |
|
Market Yield |
|
7.0% - 25.4% (17.1%) |
Subordinated debt |
|
|
547 |
|
|
Enterprise Market Value |
|
EBITDA multiple |
|
14.8x |
Equity |
|
$ |
196,398 |
|
|
Enterprise Market Value |
|
EBITDA multiple |
|
0.6x - 28.3x (10.8x) |
Total Level 3 investments |
|
$ |
2,729,010 |
|
|
|
|
|
|
|
Long-Term Credit Facility |
|
$ |
683,837 |
|
|
Market Comparable |
|
Market Yield |
|
4.8% |
(1)The weighted averages disclosed in the table above were weighted by their relative fair value.
|
| Summary of Investments, Cash and Cash Equivalents, Credit Facility, or Prior Credit Facility, Notes and Asset Backed Debt |
Our investments, cash and cash equivalents, Credit Facility, 2026 Notes, 2029 Notes, 2038-R Asset-Backed Debt, 2036-R Asset-Backed Debt, 2036 Asset-Backed Debt, and 2037 Asset-Backed Debt were categorized as follows in the fair value hierarchy for ASC 820 purposes ($ in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value at March 31, 2026 |
|
Description |
|
Fair Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Measured at Net Asset Value (1) |
|
First lien |
|
$ |
2,252,128 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,252,128 |
|
|
$ |
— |
|
Subordinate debt |
|
|
18,813 |
|
|
|
— |
|
|
|
— |
|
|
|
18,813 |
|
|
|
— |
|
Equity |
|
|
309,340 |
|
|
|
— |
|
|
|
— |
|
|
|
221,345 |
|
|
|
87,995 |
|
Total investments |
|
|
2,580,281 |
|
|
|
— |
|
|
|
— |
|
|
|
2,492,286 |
|
|
|
87,995 |
|
Cash equivalents |
|
|
31,427 |
|
|
|
31,427 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total investments and cash equivalents |
|
$ |
2,611,708 |
|
|
$ |
31,427 |
|
|
$ |
— |
|
|
$ |
2,492,286 |
|
|
$ |
87,995 |
|
Long Term Credit Facility payable |
|
$ |
328,333 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
328,333 |
|
|
$ |
— |
|
2026 Notes payable(2) |
|
|
184,998 |
|
|
|
— |
|
|
|
184,998 |
|
|
|
— |
|
|
|
— |
|
2029 Notes payable (2) |
|
|
195,868 |
|
|
|
— |
|
|
|
195,868 |
|
|
|
— |
|
|
|
— |
|
2038-R Asset-Backed Debt(2) |
|
|
284,770 |
|
|
|
— |
|
|
|
— |
|
|
|
284,770 |
|
|
|
— |
|
2036-R Asset-Backed Debt(2) |
|
|
286,585 |
|
|
|
— |
|
|
|
— |
|
|
|
286,585 |
|
|
|
— |
|
2037 Asset-Backed Debt (2) |
|
|
387,145 |
|
|
|
— |
|
|
|
— |
|
|
|
387,145 |
|
|
|
— |
|
Total debt |
|
$ |
1,667,699 |
|
|
$ |
— |
|
|
$ |
380,866 |
|
|
$ |
1,286,833 |
|
|
$ |
— |
|
——————————————— (1)In accordance with ASC Subtopic 820-10, Fair Value Measurements and Disclosures, or ASC 820-10, our equity investments in PSSL and PSSL II are measured using net asset value per share (or its equivalent) as a practical expedient for fair value, and thus have not been classified in the fair value hierarchy. (2)We elected not to apply the fair value option allowed by ASC 825-10 to the 2026 Notes, 2029 Notes, 2038-R Asset-Backed Debt, 2036-R Asset-Backed Debt, and 2037 Asset-Backed Debt and thus the balance reported in the Consolidated Statement of Assets and Liabilities represents the carrying value, which approximates the fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value at September 30, 2025 |
|
Description |
|
Fair Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Measured at Net Asset Value (1) |
|
First lien |
|
$ |
2,513,631 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,513,631 |
|
|
$ |
— |
|
Second lien and Subordinate debt |
|
|
18,981 |
|
|
|
— |
|
|
|
— |
|
|
|
18,981 |
|
|
|
— |
|
Equity |
|
|
240,716 |
|
|
|
— |
|
|
|
— |
|
|
|
196,398 |
|
|
|
44,318 |
|
Total investments |
|
|
2,773,328 |
|
|
|
— |
|
|
|
— |
|
|
|
2,729,010 |
|
|
|
44,318 |
|
Cash equivalents |
|
|
40,729 |
|
|
|
40,729 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total investments and cash equivalents |
|
$ |
2,814,057 |
|
|
$ |
40,729 |
|
|
$ |
— |
|
|
$ |
2,729,010 |
|
|
$ |
44,318 |
|
Long Term Credit Facility payable |
|
$ |
683,837 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
683,837 |
|
|
$ |
— |
|
2026 Notes payable(2) |
|
|
184,609 |
|
|
|
— |
|
|
|
184,609 |
|
|
|
— |
|
|
|
— |
|
2036 Asset-Backed Debt(2) |
|
|
284,627 |
|
|
|
— |
|
|
|
— |
|
|
|
284,627 |
|
|
|
— |
|
2036-R Asset-Backed Debt(2) |
|
|
265,366 |
|
|
|
— |
|
|
|
— |
|
|
|
265,366 |
|
|
|
— |
|
2037 Asset-Backed Debt(2) |
|
|
358,331 |
|
|
|
— |
|
|
|
— |
|
|
|
358,331 |
|
|
|
— |
|
Total debt |
|
$ |
1,776,770 |
|
|
$ |
— |
|
|
$ |
184,609 |
|
|
$ |
1,592,161 |
|
|
$ |
— |
|
(1)In accordance with ASC Subtopic 820-10, Fair Value Measurements and Disclosures, or ASC 820-10, our equity investments in PSSL is measured using net asset value per share (or its equivalent) as a practical expedient for fair value in accordance with the specialized accounting guidance for investment companies, and thus has not been classified in the fair value hierarchy. (2)We elected not to apply the fair value option allowed by ASC 825-10 to the 2026 Notes, 2036 Asset-Backed Debt, the 2036-R Asset-Backed Debt, and the 2037 Asset-Backed Debt and thus the balance reported in the Consolidated Statement of Assets and Liabilities represents the carrying value, which approximates the fair value.
|
| Reconciliation of Investments Measured at Fair Value Using Significant Unobservable Inputs Level 3 |
The tables below show a reconciliation of the beginning and ending balances for fair valued investments measured using significant unobservable inputs (Level 3) ($ in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended March 31, 2026 |
|
Description |
|
First Lien |
|
|
Second lien, subordinated debt and equity investments |
|
|
Totals |
|
Beginning balance |
|
$ |
2,513,631 |
|
|
$ |
215,379 |
|
|
$ |
2,729,010 |
|
Net realized gain (loss) |
|
|
(8,012 |
) |
|
|
1,945 |
|
|
|
(6,067 |
) |
Net change in unrealized appreciation (depreciation) |
|
|
(20,609 |
) |
|
|
24,353 |
|
|
|
3,744 |
|
Purchases, PIK interest, net discount accretion and non-cash exchanges |
|
|
394,789 |
|
|
|
7,167 |
|
|
|
401,956 |
|
Sales, repayments and non-cash exchanges |
|
|
(627,671 |
) |
|
|
(8,686 |
) |
|
|
(636,357 |
) |
Transfers in and/or out of Level 3 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Ending balance |
|
$ |
2,252,128 |
|
|
$ |
240,158 |
|
|
$ |
2,492,286 |
|
Net change in unrealized appreciation (depreciation) reported within the net change in unrealized appreciation (depreciation) on investments in our consolidated statements of operations attributable to our Level 3 assets still held at the reporting date. |
|
$ |
(25,226 |
) |
|
$ |
24,575 |
|
|
$ |
(651 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended March 31, 2025 |
|
Description |
|
First Lien |
|
|
Second lien, subordinated debt and equity investments |
|
|
Totals |
|
Beginning balance |
|
$ |
1,746,697 |
|
|
$ |
171,142 |
|
|
$ |
1,917,839 |
|
Net realized gain (loss) |
|
|
879 |
|
|
|
22,318 |
|
|
|
23,197 |
|
Net change in unrealized appreciation (depreciation) |
|
|
(18,852 |
) |
|
|
(11,597 |
) |
|
|
(30,449 |
) |
Purchases, PIK interest, net discount accretion and non-cash exchanges |
|
|
870,397 |
|
|
|
18,472 |
|
|
|
888,869 |
|
Sales, repayments and non-cash exchanges |
|
|
(498,948 |
) |
|
|
(24,720 |
) |
|
|
(523,668 |
) |
Transfers in and/or out of Level 3 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Ending balance |
|
$ |
2,100,173 |
|
|
$ |
175,615 |
|
|
$ |
2,275,788 |
|
Net change in unrealized depreciation reported within the net change in unrealized depreciation on investments in our consolidated statements of operations attributable to our Level 3 assets still held at the reporting date. |
|
$ |
(14,454 |
) |
|
$ |
7,798 |
|
|
$ |
(6,656 |
) |
|
| Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs Level 3 |
The table below shows a reconciliation of the beginning and ending balances for liabilities recognized at fair value and measured using significant unobservable inputs (Level 3)($ in thousands):
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended March 31, |
|
Long-Term Credit Facility |
|
2026 |
|
|
2025 |
|
Beginning balance (cost – $683,855 and $443,855, respectively) |
|
$ |
683,837 |
|
|
$ |
443,880 |
|
Net change in unrealized (depreciation) appreciation included in earnings |
|
|
(4 |
) |
|
|
(91 |
) |
Borrowings |
|
|
141,500 |
|
|
|
235,001 |
|
Repayments |
|
|
(497,000 |
) |
|
|
(405,000 |
) |
Ending balance (cost – $328,355 and $273,855, respectively) |
|
$ |
328,333 |
|
|
$ |
273,790 |
|
|
| Schedule of Non US Dollar Outstanding Borrowings on Credit Facility |
As of March 31, 2026, we had outstanding non-U.S. dollar borrowings on our Credit Facility. The following table shows our non-U.S. dollar borrowings as of March 31, 2026 (CAD and $ in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency |
|
Amount Borrowed |
|
|
Borrowing Cost |
|
|
Current Value |
|
|
Reset Date |
|
Unrealized appreciation (depreciation) |
|
Canadian Dollar |
|
|
CAD 2,000 |
|
|
$ |
1,455 |
|
|
$ |
1,433 |
|
|
4/1/26 |
|
|
(22 |
) |
As of September 30, 2025 we had outstanding non-U.S. dollar borrowings on our Credit Facility. The following table shows our non-U.S dollar borrowings as of September 30, 2025. (CAD and $ in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency |
|
Amount Borrowed |
|
|
Borrowing Cost |
|
|
Current Value |
|
|
Reset Date |
|
Unrealized appreciation (depreciation) |
|
Canadian Dollar |
|
|
CAD 2,000 |
|
|
$ |
1,455 |
|
|
$ |
1,437 |
|
|
10/1/2025 |
|
|
(18 |
) |
|